Norwalk Leslie V
SEC CIK 1533568 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NBIX | NEUROCRINE BIOSCIENCES INC | Dir | 2,430 | — | $3.22M | 12 | 2024-02-27 | 2026-07-29 |
| ARVN | ARVINAS, INC. | Dir | 41.6K | — | — | 4 | 2023-06-15 | 2026-06-24 |
| CVS | CVS Health | Dir | 7,376 | — | — | 4 | 2024-11-21 | 2026-05-14 |
| GMED | GLOBUS MEDICAL INC | Dir | 10.4K | — | $1.18M | 5 | 2023-09-01 | 2026-01-08 |
| CNC | Centene Corporation | Dir | 1,481 | — | — | 2 | 2022-02-07 | 2022-03-31 |
Most active insiders at NBIX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GORMAN KEVIN CHARLES | Dir | — | $37.82M |
| 2 | Cooke Julie | CHRO | — | $5.77M |
| 3 | Gano Kyle | CEO, Dir | — | $4.87M |
| 4 | Lippoldt Darin | CLO | — | $4.20M |
| 5 | SHERWIN STEPHEN A | Dir | — | $4.13M |
| 6 | Delaet Ingrid | Chief Regulatory Off | — | $3.75M |
| 7 | Onyia Jude | CSO | — | $3.47M |
| 8 | RASTETTER WILLIAM H | Dir | — | $2.73M |
| 9 | POPS RICHARD F | Dir | — | $2.36M |
| 10 | LYONS GARY A | Dir | — | $2.29M |
| 12 | Norwalk Leslie V | Dir | — | $1.97M |
Transactions 27
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-30 17:29 | 2026-07-28 | NBIX | NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Dir | S - Sale+OE | $182.01 | -1,250 | 1,588 | -44% | -$227.5K |
| DT | 2026-07-30 17:29 | 2026-07-29 | NBIX | NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Dir | M - OptEx | $139.43 | +842 | 2,430 | +53% | +$117.4K |
| D | 2026-06-26 16:23 | 2026-06-24 | ARVN | ARVINAS, INC. | Norwalk Leslie V | Dir | A - Grant | $0.00 | +15.5K | 41.6K | +60% | $0 |
| T | 2026-06-08 18:07 | 2026-06-04 | NBIX | NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Dir | S - Sale | $168.06 | -1,250 | 2,838 | -31% | -$210.1K |
| D | 2026-05-21 19:22 | 2026-05-21 | NBIX | NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Dir | M - OptEx | $0.00 | +1,659 | 4,088 | +68% | $0 |
| 2026-05-15 17:12 | 2026-05-14 | CVS | CVS Health | Norwalk Leslie V | Dir | A - Grant | $97.15 | +1,447 | 7,376 | +24% | +$140.6K | |
| T | 2026-05-14 16:45 | 2026-05-12 | NBIX | NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Dir | S - Sale | $155.01 | -3,810 | 2,429 | -61% | -$590.6K |
| T | 2026-01-12 | 2026-01-08 | GMED | GLOBUS MEDICAL INC | Norwalk Leslie V | Dir | S - Sale | $101.10 | -2,000 | 10.4K | -16% | -$202.2K |
| DM | 2025-12-17 | 2025-12-15+ | NBIX | NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Dir | S - Sale+OE | $152.78 | -6,190 | 6,239 | -50% | -$945.7K |
| DM | 2025-12-17 | 2025-12-15 | NBIX | NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Dir | M - OptEx | $91.07 | +10.0K | 10.7K | +1,418% | +$910.7K |
| T | 2025-12-16 | 2025-12-12 | GMED | GLOBUS MEDICAL INC | Norwalk Leslie V | Dir | S - Sale | $88.85 | -4,000 | 12.4K | -24% | -$355.4K |
| 2025-11-21 | 2025-11-20 | CVS | CVS Health | Norwalk Leslie V | Dir | A - Grant | $76.04 | +1,652 | 5,929 | +39% | +$125.6K | |
| D | 2025-06-27 | 2025-06-25 | ARVN | ARVINAS, INC. | Norwalk Leslie V | Dir | A - Grant | $0.00 | +16.0K | 26.0K | +160% | $0 |
| D | 2025-05-22 | 2025-05-22 | NBIX | NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Dir | M - OptEx | $0.00 | +1,435 | 2,429 | +144% | $0 |
| 2025-05-19 | 2025-05-15 | CVS | CVS Health | Norwalk Leslie V | Dir | A - Grant | $60.47 | +2,077 | 4,277 | +94% | +$125.6K | |
| 2024-11-25 | 2024-11-21 | CVS | CVS Health | Norwalk Leslie V | Dir | A - Grant | $57.10 | +2,200 | 2,200 | New | +$125.6K | |
| T | 2024-07-15 | 2024-07-11 | GMED | GLOBUS MEDICAL INC | Norwalk Leslie V | Dir | S - Sale | $70.00 | -1,000 | 16.4K | -6% | -$70.0K |
| D | 2024-05-31 | 2024-05-29 | ARVN | ARVINAS, INC. | Norwalk Leslie V | Dir | A - Grant | $0.00 | +5,899 | 10.0K | +143% | $0 |
| D | 2024-05-21 | 2024-05-17 | NBIX | NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Dir | M - OptEx | $0.00 | +2,100 | 2,100 | New | $0 |
| D | 2024-05-21 | 2024-05-17 | NBIX | NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Dir | S - Sale+OE | $141.82 | -1,106 | 994 | -53% | -$156.9K |
| T | 2024-03-19 | 2024-03-15 | GMED | GLOBUS MEDICAL INC | Norwalk Leslie V | Dir | S - Sale | $51.99 | -10.6K | 17.4K | -38% | -$550.6K |
| D | 2024-02-29 | 2024-02-27 | NBIX | NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Dir | M - OptEx | $84.95 | +8,000 | 8,000 | New | +$679.6K |
| D | 2024-02-29 | 2024-02-27 | NBIX | NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Dir | S - Sale+OE | $135.67 | -8,000 | 0 | -100% | -$1.09M |
| DM | 2023-09-06 | 2023-09-01 | GMED | GLOBUS MEDICAL INC | Norwalk Leslie V | Dir | A - Grant | — | +28.0K | 2,321 | New | — |
| D | 2023-06-20 | 2023-06-15 | ARVN | ARVINAS, INC. | Norwalk Leslie V | Dir | A - Grant | $0.00 | +4,121 | 4,121 | New | $0 |
| 2022-04-04 | 2022-03-31 | CNC | Centene Corporation | Norwalk Leslie V | Dir | A - Grant | $82.02 | +381.01 | 1,481 | +35% | +$31.3K | |
| D | 2022-02-09 | 2022-02-07 | CNC | Centene Corporation | Norwalk Leslie V | Dir | A - Grant | $0.00 | +1,100 | 1,100 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations